Literature DB >> 26893988

Tissue Expanders in Skin Deficient Ventral Hernias Utilizing Component Separation.

Francisco J Agullo1, Vanessa E Molinar1, Alonso Molinar1, Humberto Palladino1.   

Abstract

Skin deficient complex ventral hernias are complicated surgical cases that have multimodal approaches. There is no current consensus on the management of those patients who also have concomitant stomas or enterocutaneous fistula. We present 2 cases in which the senior authors were able to apply tissue expanders above and between the abdominal wall in patients with an enterocutaneous fistula or stoma. After expansion and final closure, the patients did not experience recurrent hernias.

Entities:  

Year:  2015        PMID: 26893988      PMCID: PMC4727715          DOI: 10.1097/GOX.0000000000000515

Source DB:  PubMed          Journal:  Plast Reconstr Surg Glob Open        ISSN: 2169-7574


Complicated hernias usually include those in patients with obesity, diabetes, smokers, and other comorbidities or in the presence of enterocutaneous fistulas (ECFs), multiple recurrent hernias, mesh infection, and hernias after trauma or tumor resection.[1-3] One of the most significant challenges in abdominal wall reconstruction are patients with a large abdominal wall defect in conjunction with an ECF or stoma.[4] An extensive literature review performed by the authors up to January 2015 revealed only 6 publications on the use of tissue expanders to reconstruct ventral hernias, none of which discussed the importance of specific anatomic placement of tissue expanders during simultaneous repair of the hernia with underlying ECF or stomas.[1,5-9] We report 2 patients with skin deficient incisional ventral hernias with these underlying conditions.

CLINICAL REPORTS

CUI Tissue Expanders (Allergan, Newport, Calif.) were strategically placed in different anatomic locations because of underlying ECF in patient 1 and a stoma in patient 2. After 10 weeks of expansion to a final volume of 1000 mL per expander, the patients underwent definitive closure by removal of the tissue expander, excision of split thickness skin graft (STSG), restoration of bowel continuity, ventral hernia repair utilizing biologic mesh underlay, bilateral component separation technique (CST), and primary skin closure.

Case 1

A 64-year-old man who had undergone previous laparoscopic bilateral inguinal hernia repair experienced complications from bowel perforation. After several subsequent surgeries and the development of an acute abdomen, he developed a chronic ECF and flank abscess. The patient subsequently received an STSG to the chronic open abdominal wound and fistula. At 3-month follow-up, it was noted that a low output fistula developed in the right lower quadrant after incision and drainage of an abscess in this location. He also had a hernia that extended from the pubis up to the xyphoid, and the costal margins formed the upper borders of the hernia. Four tissue expanders were placed above the abdominal wall fascia in close proximity to the ventral defect. They were expanded weekly until they reached their final volume. Expansion process was tolerated well (Fig. 1).
Fig. 1.

Preoperative appearance after tissue expansion.

Preoperative appearance after tissue expansion. Closure was planned 9 months later. The fistula was identified as 20 cm proximal to the terminal ileum and removed by a segmental enterectomy. The tissue expanders were removed, and the 30 × 20 cm2 STSG was excised. After colonic anastomosis was achieved, the hernia was repaired utilizing the bilateral CST and a 20 × 40 cm2 Permacol biological mesh underlay (Covidien, New Haven, Conn.). Complete rectus muscle approximation was obtained with complete closure. The stretched skin reached the mid line, and there were no surgical complications. At 3-year follow-up, the patient did not have any complications or recurrence (Fig. 2).
Fig. 2.

Postoperative appearance after 12 months.

Postoperative appearance after 12 months.

Case 2

A 59-year-old woman presented with perforated diverticulitis and subsequently experienced a complicated hospital course that led to the development of an ECF, open abdomen, and a colonic stent to obtain fecal diversion through a left upper quadrant colostomy. Physical examination revealed a large ventral hernia with a 25 × 20 cm2 wound managed by negative pressure therapy. Once the ECF was controlled, an STSG was applied to the granulated wound. Sixteen months later, tissue expanders were placed in the presence of a colostomy. Two expanders measuring 500 mL on the left and 700 mL on the right were placed in each lateral abdominal wall, between the external and internal oblique. After 10 weeks of expansion (Fig. 3), the 25 × 18 cm2 STSG was excised and the tissue expanders were removed. The hernia was repaired utilizing the bilateral CST and underlay Strattice mesh (LifeCell, Bridgewater, N.J.). A more acceptable midline scar was obtained with complete approximation. No recurrence at 22-month follow-up (Fig. 4).
Fig. 3.

Preoperative appearance.

Fig. 4.

Postoperative appearance after 22 months.

Preoperative appearance. Postoperative appearance after 22 months.

DISCUSSION

Reconstruction of the abdominal wall in patients with underlying medical issues can interfere with the sterility of surgical repair and also present with unique challenges.[10] The use of prosthetic or biological mesh in conjunction with tissue-expanded skin provides a durable abdominal closure for these patients.[11] Biologic meshes have shown success in decreased risk of recurrence in contaminated operation fields.[12] In our study, our patients did not experience any complications from the use of biologic mesh nor infectious complications with the use of tissue expanders. We believe that specific anatomic positioning and presurgical planning determines success of reconstruction in this setting. The tissue expanders were placed between the external and internal oblique muscles in patient 2, which allowed expansion of skin and abdominal wall musculature. This subsequently allows for successful dissection and completion of a components’ separation at the time of expander removal, never interfering with a stoma, which lies within the rectus, and avoiding inadvertent enterotomy. In the absence of a colostomy, patient 1 was treated with expanders above the muscle to capitalize on maximum skin expansion. Pocket dissection on the right was limited to avoid communication with the ECF. Because these are clean-contaminated cases, the risk of infection or expander contamination is greater. We used standard perioperative antibiotic protocol and extended oral antibiotics while the drains were in place. What is unique about the experiences described in this article is the use of tissue expanders to successfully close skin deficient, complicated ventral hernias both arising from an infected abdomen, further complicated by the development of a subsequent ECF and stoma. Previous reports have recommended that closure of all abdominal stomas and ECF should precede attempts at abdominal reconstruction.[13] Further studies should aim to clarify the best anatomical position of the tissue expanders in these situations using an evidence-based approach to improve patient outcomes and quality of life.

ACKNOWLEDGMENTS

The authors thank Jessica Chavez, BS, for assistance with study design and approval. The authors also appreciate the editorial assistance of Alan H. Tyroch, MD, FACS, Professor and Chair for the Department of Surgery at Texas Tech University Health Sciences Center at El Paso, Paul L. Foster School of Medicine.
  13 in total

1.  The role of tissue expansion in abdominal wall reconstruction.

Authors:  G W Carlson; E Elwood; A Losken; J R Galloway
Journal:  Ann Plast Surg       Date:  2000-02       Impact factor: 1.539

2.  A comparison of suture repair with mesh repair for incisional hernia.

Authors:  R W Luijendijk; W C Hop; M P van den Tol; D C de Lange; M M Braaksma; J N IJzermans; R U Boelhouwer; B C de Vries; M K Salu; J C Wereldsma; C M Bruijninckx; J Jeekel
Journal:  N Engl J Med       Date:  2000-08-10       Impact factor: 91.245

3.  "Components separation" method for closure of abdominal-wall defects: an anatomic and clinical study.

Authors:  O M Ramirez; E Ruas; A L Dellon
Journal:  Plast Reconstr Surg       Date:  1990-09       Impact factor: 4.730

4.  Complex hernia repair using component separation technique paired with intraperitoneal acellular porcine dermis and synthetic mesh overlay.

Authors:  Hossein Nasajpour; Karl A LeBlanc; Matthew H Steele
Journal:  Ann Plast Surg       Date:  2011-03       Impact factor: 1.539

5.  Massive ventral hernias: role of tissue expansion in abdominal wall restoration following abdominal compartment syndrome.

Authors:  Anthony A Admire; Matthew O Dolich; Amy C Sisley; Kian J Samimi
Journal:  Am Surg       Date:  2002-05       Impact factor: 0.688

6.  Repair of a postappendectomy massive ventral hernia using tissue expanders.

Authors:  Yeliz Emine Ersoy; Fatih Celebi; Fazilet Erozgen; Selma Sonmez Ergun; Murat Akaydin; Rafet Kaplan
Journal:  J Korean Surg Soc       Date:  2012-12-26

7.  Outcomes of simultaneous large complex abdominal wall reconstruction and enterocutaneous fistula takedown.

Authors:  David M Krpata; Sharon L Stein; Michelle Eston; Bridget Ermlich; Jeffrey A Blatnik; Yuri W Novitsky; Michael J Rosen
Journal:  Am J Surg       Date:  2013-01-30       Impact factor: 2.565

Review 8.  Biologic grafts for ventral hernia repair: a systematic review.

Authors:  Nicholas J Slater; Marion van der Kolk; Thijs Hendriks; Harry van Goor; Robert P Bleichrodt
Journal:  Am J Surg       Date:  2012-11-30       Impact factor: 2.565

Review 9.  Options for closure of the infected abdomen.

Authors:  Kristin C Turza; Chris A Campbell; Laura H Rosenberger; Amani D Politano; Stephen W Davies; Lin M Riccio; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2012-12-10       Impact factor: 2.150

10.  Tissue expanders for abdominal wall reconstruction following severe trauma: technical note and case reports.

Authors:  D H Livingston; P K Sharma; A I Glantz
Journal:  J Trauma       Date:  1992-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.